Skip to main content

Table 2 Comparison of BCVA, Visual field MD and Outer Retinal Thickness values at baseline and final examination (6th month)

From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results

ParametresBaselineFinalp%95 CI (L, U)
X ± SDX ± SD
BCVA70,5 ± 15,7180,62 ± 16,260,01*(−12,33, −7,9)
Visual field MD27,25 ± 3,4124,72 ± 5,980,01*(1,05, 4,00)
Outer Retinal Thickness100,26 ± 15,64119,11 ± 17,070,01*(−25,42, −13,26)
  1. BCVA, best-corrected visual acuity; ETDRS, early treatment of diabetic retinopathy study charts (letters point);
  2. MD, mean deviation (dB)
  3. Outer retinal thickness (μm)
  4. %95 CI L and U, 95% confidence interval of the difference (mean)
  5. * Bold: Statistically signigicant